Buy now, pay later (BNPL) products, which offer interest-free credit, can now be used to pay for weight-loss drugs. Obiflex,...
GLP1
As recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like peptide 1 agonist,...
Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—most...
Walmart has largely built its empire on two things: groceries and pharmacy. The retailer is the third-largest pharmacy operator in...
La Marca, a retired professor living in Basking Ridge, New Jersey, is among an estimated 5.9 million Medicare enrollees excluded...
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair — the...
NFL legend and eMed Chief Wellness Officer Tom Brady and eMed CEO Linda Yaccarino discuss eMed's mission on 'The Claman...
It's been about five years since the U.S. Food and Drug Administration approved Wegovy for chronic weight management, but semaglutide,...
David Protein CEO: GLP-1 drugs killed diet trends—and is making the future of food harder to predict
Every January, David Protein founder and CEO Peter Rahal knew what to expect: the emergence of a new diet trend...
Medicare beneficiaries may soon have a less expensive way to obtain certain GLP-1 medications prescribed for weight loss, while workers...
Eli Lilly (LLY) stock initially sold off on Monday morning, May 4, after the FDA disclosed a liver failure report...
Center for Medicare Director Chris Klomp joins ‘Mornings with Maria’ to outline the Trump administration’s latest Medicare rate update, defend...
When the size-inclusivity movement gained momentum, it revolutionized the fashion industry, pushing many apparel companies to expand beyond traditional sizing...
eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss GLP-1 market growth and the company’s latest funding...